Total trials
378
Active
75
Phase 3
15
Total enrollment
107,886
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Naltrexone/Bupropion | — | — | — | — | — | 1 | |
| Activated Charcoal | — | — | — | — | — | 1 | |
| Cyproheptadine 4 Mg Oral | — | — | — | — | — | 1 | |
| Heparin | — | — | — | — | 2 | ||
| Mepolizumab | — | — | — | — | — | 1 | |
| Lemborexant | — | — | — | — | — | 1 | |
| Incretin-Based Treatment | — | — | — | — | — | 1 |
Next readouts
- 2024-12-31
- 2026-06-01
- 2026-09
- 2027-01
- 2027-02
- 2028-03
- 2028-06
Top conditions
- Obesity25
- Asthma22
- Metabolic Syndrome16
- Chronic Obstructive Pulmonary Disease15
- Insulin Resistance9
- Cardiovascular Disease8
- Overweight8
- Respiratory Failure7
Frequently asked questions about Laval University
- How many clinical trials does Laval University have on ClinicalTrials.gov?
- Laval University is listed as the lead sponsor on 378 clinical trials in ClinicalTrials.gov, 75 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Laval University's trials are in Phase 3?
- 15 of Laval University's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Laval University focus on?
- Laval University's most-studied conditions on ClinicalTrials.gov are Obesity, Asthma, Metabolic Syndrome, Chronic Obstructive Pulmonary Disease, Insulin Resistance.
- When are Laval University's next clinical trial readouts?
- Laval University has 7 upcoming primary-completion readouts tracked here; the soonest is “Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery”, expected around 2024-12-31.